<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000660.v1.p1" parentStudy="phs000660.v1.p1" createDate="2013-08-30" modDate="2014-06-02">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Yuehua Zhang</td><td>Department of Pediatrics, Peking University First Hospital, Beijing, China</td></tr>
		<tr><td>Principal Investigator</td><td>Liping Wei</td><td>Center for Bioinformatics, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University; National Institute of Biological Sciences, ZGC Life Science Park, Beijing, China</td></tr>
		<tr><td>Funding Source</td><td>BMU20120308</td><td>Key Construction Program of the National &quot;985&quot; Project, Ministry of Science and Technology of China, Beijing, China</td></tr>
		<tr><td>Funding Source</td><td>31025014</td><td>National Outstanding Young Investigator Award, Beijing, China</td></tr>
		<tr><td>Funding Source</td><td>2012CB837600</td><td>Ministry of Science and Technology of China, Beijing, China</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Chinese Alternating Hemiplegia of Childhood (AHC) Disease Study</StudyNameEntrez>
	<StudyNameReportPage>Chinese Alternating Hemiplegia of Childhood (AHC) Disease Study</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Parent-Offspring Trios</StudyType>
		<StudyType>Case Set</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>AHC is a rare and severe neurological disorder, and characterized by episodic hemiplegia or quadriplegia attacks, accompanied by other paroxysmal symptoms of oculomotor abnormalities, dystonia, seizures and autonomic disturbances; the age of onset usually occurrs before 18 months of life. Sodium-potassium ATPase alpha3 subunit (ATP1A3) has recently been identified as a causal gene for sporadic AHC by three groups. However, there has not been any large genetic study on a Chinese cohort.</p> <p>In the submitted data, whole-exome sequencing of three trios and three sporadic cases in a Chinese cohort produced an average of 18.8 gigabases of raw sequence. Through our analysis pipeline including BWA mapping, GATK recalibration, variant calling and filtering, all six patients contained missense mutations in ATP1A3 which were further confirmed as <i>de novo</i> mutations. Along with validation in additional patients, this study confirmed ATP1A3 as a causal gene in Chinese AHC patients, and reported six novel mutations. </p>]]>
	</Description>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="24842602"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Alternating hemiplegia of childhood"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Yuehua Zhang</AttName>
			<Institution>Department of Pediatrics, Peking University First Hospital, Beijing, China</Institution>
		</Header>
		<Header title="Principal Investigator">
			<AttName>Liping Wei</AttName>
			<Institution>Center for Bioinformatics, State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking University; National Institute of Biological Sciences, ZGC Life Science Park, Beijing, China</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>BMU20120308</AttName>
			<Institution>Key Construction Program of the National &quot;985&quot; Project, Ministry of Science and Technology of China, Beijing, China</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>31025014</AttName>
			<Institution>National Outstanding Young Investigator Award, Beijing, China</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>2012CB837600</AttName>
			<Institution>Ministry of Science and Technology of China, Beijing, China</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyHistory><![CDATA[
<p>The diagnosis was made according to clinical diagnostic criteria for typical AHC as described in <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=8496742">Bourgeois et al. 1993</a>, and <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20974617">Panagiotakaki et al. 2010</a>. For trios those, where parents were normal while a child was diagnosed with AHC, were selected. </p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="GRU" longName="General Research Use"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NINDS</DacName>
      <DacFullName>National Institute of Neurological Disorders and Stroke</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000660.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>12</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000660.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000660.v1.p1" FileName="DUC-Causal_gene_identification_in_Chinese_Alternating_Hemiplegia_of_Childhood_patients.pdf"/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>General Research Use</ConsentName>
        <ConsentAbbrev>GRU</ConsentAbbrev>
        <UseLimitation>Use of the data is limited only by the terms of the model Data Use Certification.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
